Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2012
Headcount
6
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences
About
Novo Path develops preventive airway management solutions to minimize complications and improve medical care formechanically ventilated patients. The company is developing its flagship product, the NovoPath, a disposable endotracheal tube (ETT) lining enabling instant replacement of the entire ETT inner surface, thus preventing the accumulation of bacteria, fungi, and other bio burden.
Q&A
- What is Novo Path's primary focus?
- Novo Path develops preventive airway management solutions to minimize complications and improve medical care for mechanically ventilated patients.
- What is Novo Path's flagship product?
- Novo Path's flagship product is the NovoPath, a disposable endotracheal tube (ETT) lining that enables instant replacement of the entire ETT inner surface to prevent the accumulation of bacteria, fungi, and other bio burden.
- When was Novo Path founded?
- Novo Path was founded in January 2012.
- Where is Novo Path headquartered?
- Novo Path is headquartered in Nazareth, Israel.
- What is Novo Path's current operational status?
- Novo Path is currently inactive, as of November 2016.
- Who is the founder of Novo Path?
- The founder of Novo Path is Arie Ben Josef.
- In which sector does Novo Path primarily operate?
- Novo Path primarily operates in the Health Tech & Life Sciences sector.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife Support
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
hospitalspreventionrespiratorymedical-devicesventilation
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2012-1 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Nov 2016 |